Veradermics, Inc. (MANE)
122.28
+13.46
(+12.37%)
USD |
NYSE |
Oct 19, 16:00
128.00
+5.72
(+4.68%)
Pre-Market: 04:21
Veradermics EPS Diluted (Quarterly) : -0.5625 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5625 |
| March 31, 2026 | -0.8037 |
| December 31, 2025 | -0.7554 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.4824 |
| March 31, 2025 | -0.3905 |
| December 31, 2024 | -0.1846 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.939 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 0.0858 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.50M |
| Total Expenses (Quarterly) | 23.50M |
| Enterprise Value | 4.289B |
| Earnings Yield | -2.13% |
| Normalized Earnings Yield | -2.130 |